Efficacy of Low-Dose Laser Acupuncture for Low Back Pain
Not yet recruitingNot applicableNCT07461363
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study will evaluate whether low-dose laser acupuncture can reduce pain and improve daily function in adults with chronic low back pain. The trial is a double-blinded, randomized, two-arm, parallel, multi-centred study.
Study details
- Official title
- Effect of Low-Dose Laser Acupuncture on Low Back Pain: A Randomised Control Trial
- Conditions
- Interventions
- Device: Low-Dose Laser Acupuncture
- Device: Sham Laser Acupuncture
- Sponsor
- Mun Fei Yam
- Organization
- Universiti Sains Malaysia
- Start date
- 2026-09-01
- Primary completion
- 2028-02-15
- Sex
- All
- Age range
- from 18 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- China
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Low back pain for ≥12 weeks * Pain intensity VAS ≥3 cm at Visit 1 (baseline) * Age 18-65 years * Able and willing to provide written informed consent * Able and willing to attend treatment sessions at Pusat Sejahtera, Universiti Sains Malaysia and complete the 3-month follow-up phone assessment Exclusion Criteria: * Pregnant or planning pregnancy; females unwilling to use pregnancy prevention during the study * Current or past history of trauma or cancer * Prior spine surgery * Severe infection (e.g., tuberculosis, pyogenic abscess) * Fever ≥38°C lasting ≥48 hours at recruitment * Cauda equina syndrome * Significant spinal cord compression with serious disability (per medical history) * Osteoporosis requiring pharmacologic treatment * Severe dementia, cognitive impairment, other major cerebral disease, or severe psychiatric/psychological disorder * Significant renal or hepatic disease * BMI ≥34.9 kg/m² * History of recreational drug abuse * Use of systemic steroids within the past 6 months * Use of any analgesics (including paracetamol) within the past 30 days * Acupuncture treatment within the past 30 days
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07461363